These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 11925670

  • 1. [Role of the steroids, SHBG, IGF-1, IGF BP-3 and growth hormone in glucose metabolism disorders during long-term treatment with low doses of glucocorticoids].
    Vondra K, Hampl R, Nĕmcová D, Hill M, Hoza J, Kot'átková A, Stárka L, Vrbíková J, Zamrazil V.
    Cas Lek Cesk; 2002 Feb 15; 141(3):89-95. PubMed ID: 11925670
    [Abstract] [Full Text] [Related]

  • 2. [Metformin has a positive effect on disorders of carbohydrate metabolism in long-term care with low doses of prednisone].
    Vondra K, Nĕmcová D, Stárka L, Bílek R, Bendlová B, Hampl R, Hill M, Hoza J, Kot'átková A, Vrbíková J, Zamrazil V.
    Cas Lek Cesk; 2002 Apr 26; 141(8):255-60. PubMed ID: 12038076
    [Abstract] [Full Text] [Related]

  • 3. Metformin therapy increases insulin-like growth factor binding protein-1 in hyperinsulinemic women with polycystic ovary syndrome.
    Pawelczyk L, Spaczynski RZ, Banaszewska B, Duleba AJ.
    Eur J Obstet Gynecol Reprod Biol; 2004 Apr 15; 113(2):209-13. PubMed ID: 15063962
    [Abstract] [Full Text] [Related]

  • 4. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.
    Vermeulen A, Kaufman JM, Giagulli VA.
    J Clin Endocrinol Metab; 1996 May 15; 81(5):1821-6. PubMed ID: 8626841
    [Abstract] [Full Text] [Related]

  • 5. Treatment of hypoglycemia using combined glucocorticoid and recombinant human growth hormone in a patient with a metastatic non-islet cell tumor hypoglycemia.
    Bourcigaux N, Arnault-Ouary G, Christol R, Périn L, Charbonnel B, Le Bouc Y.
    Clin Ther; 2005 Feb 15; 27(2):246-51. PubMed ID: 15811488
    [Abstract] [Full Text] [Related]

  • 6. Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low-dose GH therapy in adults with severe GH deficiency.
    Yuen KC, Dunger DB.
    Clin Endocrinol (Oxf); 2006 May 15; 64(5):549-55. PubMed ID: 16649975
    [Abstract] [Full Text] [Related]

  • 7. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM, van Doorn J, Stijnen T, Drop SL, de Muinck Keizer-Schrama SM.
    Clin Endocrinol (Oxf); 2006 Sep 15; 65(3):310-9. PubMed ID: 16918949
    [Abstract] [Full Text] [Related]

  • 8. Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancer.
    De Marinis L, Mancini A, Izzi D, Bianchi A, Giampietro A, Fusco A, Liberale I, Rossi S, Valle D.
    Clin Endocrinol (Oxf); 2000 Jun 15; 52(6):681-5. PubMed ID: 10848871
    [Abstract] [Full Text] [Related]

  • 9. Dehydroepiandrosterone supplementation in women with adrenal failure: impact on twenty-four hour GH secretion and IGF-related parameters.
    Christiansen JJ, Gravholt CH, Fisker S, Svenstrup B, Bennett P, Veldhuis J, Andersen M, Christiansen JS, Jørgensen JO.
    Clin Endocrinol (Oxf); 2004 Apr 15; 60(4):461-9. PubMed ID: 15049961
    [Abstract] [Full Text] [Related]

  • 10. Sex hormone-binding globulin as a marker of the effect of hormonal treatment in Turner's syndrome.
    Hampl R, Snajderova M, Lebl J, Lisa L, Dvorakova M, Hill M, Sulcova J, Starka L.
    Endocr Regul; 2001 Mar 15; 35(1):17-24. PubMed ID: 11308992
    [Abstract] [Full Text] [Related]

  • 11. C-peptide, IGF-I, sex-steroid hormones and adiposity: a cross-sectional study in healthy women within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Bezemer ID, Rinaldi S, Dossus L, Gils CH, Peeters PH, Noord PA, Bueno-de-Mesquita HB, Johnsen SP, Overvad K, Olsen A, Tjønneland A, Boeing H, Lahmann PH, Linseisen J, Nagel G, Allen N, Roddam A, Bingham S, Khaw KT, Kesse E, Téhard B, Clavel-Chapelon F, Agudo A, Ardanaz E, Quiros JR, Amiano P, Martínez-Garcia C, Tormo MJ, Pala V, Panico S, Vineis P, Palli D, Tumino R, Trichopoulou A, Baibas N, Zilis D, Hémon B, Norat T, Riboli E, Kaaks R.
    Cancer Causes Control; 2005 Jun 15; 16(5):561-72. PubMed ID: 15986111
    [Abstract] [Full Text] [Related]

  • 12. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P, Díez JJ, Fernández-Reyes MJ, Méndez J, Bajo MA, Aguilera A, Selgas R.
    Clin Endocrinol (Oxf); 2004 Jun 15; 60(6):741-9. PubMed ID: 15163339
    [Abstract] [Full Text] [Related]

  • 13. Relationship of plasma adiponectin with sex hormone and insulin-like growth factor levels.
    Tworoger SS, Mantzoros C, Hankinson SE.
    Obesity (Silver Spring); 2007 Sep 15; 15(9):2217-24. PubMed ID: 17890489
    [Abstract] [Full Text] [Related]

  • 14. The effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenaemia, SHBG and lipids in PCOS patients.
    Cibula D, Fanta M, Vrbikova J, Stanicka S, Dvorakova K, Hill M, Skrha J, Zivny J, Skrenkova J.
    Hum Reprod; 2005 Jan 15; 20(1):180-4. PubMed ID: 15576394
    [Abstract] [Full Text] [Related]

  • 15. Conjugated estrogen/progestagen versus tibolone hormone replacement therapy in postmenopausal women: Effects on carbohydrate metabolism and serum sex hormone-binding globulin.
    Odmark IS, Carlström K, Jonsson B, Jonasson AF.
    Maturitas; 2006 Jan 10; 53(1):89-96. PubMed ID: 15964160
    [Abstract] [Full Text] [Related]

  • 16. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
    Robaczyk MG.
    Ann Acad Med Stetin; 2002 Jan 10; 48():283-300. PubMed ID: 14601484
    [Abstract] [Full Text] [Related]

  • 17. Reduced androgen levels in adult turner syndrome: influence of female sex steroids and growth hormone status.
    Gravholt CH, Svenstrup B, Bennett P, Sandahl Christiansen J.
    Clin Endocrinol (Oxf); 1999 Jun 10; 50(6):791-800. PubMed ID: 10468952
    [Abstract] [Full Text] [Related]

  • 18. The effects of metformin and diet on plasma testosterone and leptin levels in obese men.
    Ozata M, Oktenli C, Bingol N, Ozdemir IC.
    Obes Res; 2001 Nov 10; 9(11):662-7. PubMed ID: 11707532
    [Abstract] [Full Text] [Related]

  • 19. Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women.
    Diamond P, Cusan L, Gomez JL, Bélanger A, Labrie F.
    J Endocrinol; 1996 Sep 10; 150 Suppl():S43-50. PubMed ID: 8943786
    [Abstract] [Full Text] [Related]

  • 20. Characterization of the IGF system in 15 patients with Alström syndrome.
    Maffei P, Boschetti M, Marshall JD, Paisey RB, Beck S, Resmini E, Collin GB, Naggert JK, Milan G, Vettor R, Minuto F, Sicolo N, Barreca A.
    Clin Endocrinol (Oxf); 2007 Feb 10; 66(2):269-75. PubMed ID: 17223998
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.